News
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
8h
MedPage Today on MSNRFK Jr. Threatens Publishing Ban; Obesity Drug Costs Fall; Nurses' Brain Tumor ProbeHHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...
Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...
Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...
Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...
California Healthline: Silence On E. Coli Outbreak Highlights How Trump Team’s Changes Undermine Food Safety Food ...
Despite their widely touted benefits — primarily weight loss and diabetes control, among others — GLP-1 medications have also ...
HHS Secretary RFK Jr. removes the COVID-19 vaccine recommendation for healthy kids and pregnant women—the latest in a string of changes to vaccine policies; judge issues an order to halt HHS’ ...
GLP-1 drugs like Ozempic are revolutionizing diabetes care. But they’re also making users less likely to drink alcohol. That ...
President Trump on Wednesday punted on a question about tech billionaire Elon Musk’s criticism of the “big, beautiful bill” packed with the president’s legislative priorities the House passed last ...
Elon Musk is criticizing the centerpiece of President Donald Trump’s legislative agenda, saying he's “disappointed” in what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results